首页> 外国专利> VISIBLE LIGHT-INDUCED RETINOPATHY INHIBITOR, AND EYE DISEASE PREVENTING AND THERAPEUTIC AGENT USING THE SAME

VISIBLE LIGHT-INDUCED RETINOPATHY INHIBITOR, AND EYE DISEASE PREVENTING AND THERAPEUTIC AGENT USING THE SAME

机译:可见光诱导的视网膜病变抑制剂,使用相同的预防和眼病治疗剂

摘要

PROBLEM TO BE SOLVED: To provide a light-induced retinopathy inhibitor, which includes a new ingredient as an active ingredient.;SOLUTION: (1) The light-induced retinopathy inhibitor includes an extract of Maqui berry as an active ingredient. (2) The light-induced retinopathy inhibitor includes delphinidin and/or a glycoside thereof (formula) as an active ingredient. Furthermore, when the active ingredient is extracted from Maqui berry, a part to be extracted is not specifically limited, for example, a fruit, a seed, a flower, a leaf, a root, a stem, and the like can be used, and in particular a fruit is preferably used because the active ingredient can be extracted with high concentration.;COPYRIGHT: (C)2013,JPO&INPIT
机译:解决的问题:提供一种光诱导性视网膜病抑制剂,其包括新成分作为有效成分。解决方案:(1)光诱导性视网膜病抑制剂以马奎莓提取物为有效成分。 (2)光诱导性视网膜病抑制剂以飞燕草素和/或其糖苷(式)为有效成分。此外,当从马基浆果提取活性成分时,对提取的部分没有特别限制,例如,可以使用水果,种子,花,叶,根,茎等。尤其是水果,因为可以有效地提取有效成分。;版权所有:(C)2013,日本特许厅

著录项

  • 公开/公告号JP2013163669A

    专利类型

  • 公开/公告日2013-08-22

    原文格式PDF

  • 申请/专利权人 ORIZA YUKA KK;

    申请/专利号JP20120104891

  • 申请日2012-05-01

  • 分类号A61K36/18;A61K36/00;A61P27/02;A61K31/353;A61K31/7048;A61P27/12;A61P27/06;C07D311/62;C07H17/065;

  • 国家 JP

  • 入库时间 2022-08-21 17:02:22

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号